Interviews

Will Lewis

2024-03-08

The company aims to maintain a high level of education and awareness to ensure that those affected by refractory MAC lung disease are aware of ARIKAYCE, reflecting a commitment to making a long-term impact on patient care.

Pamela Spence

Global Health Sciences and Wellness Industry Leader

2024-03-08

AI in the pharmaceutical industry is often overestimated in the short term and underestimated in the long term.

Jeffrey Dayno, MD

President and Chief Executive Officer

Harmony Biosciences

2024-03-07

Absolutely, there's a growing awareness about the significant impact of orphan diseases which, though individually rare, collectively affect about 30 million individuals in the US.

Tom Langan

President and Chief Commercial Officer

Veradigm

2024-03-06

The life science industry is highly regulated, making it essential to have proper consents, privacy, and compliance measures in place.

Rob Henderson

CEO

BioTalent Canada

2024-02-29

Despite the dire need for talent, the Canadian bio-economy has not achieved diversity.

Debashis Ghosh

President of the Life Sciences, Healthcare - Energy - Resources and Utilities Business Group

Tata Consultancy Services

2024-02-28

Gene editing has transitioned from laboratory research to real-world applications, particularly in treating complex illnesses such as sickle cell disease.

Laura Niklason

President & CEO

Humacyte Global Inc.

2024-02-27

Our success in engineering blood vessels that integrate well with the human body and support arterial blood flow opens the door to broader applications in regenerative medicine, including treating type 1 diabetes.